Core Viewpoint - 10x Genomics, Inc. will report its financial results for Q4 and the full year ended December 31, 2025, on February 12, 2026, after market close, followed by a conference call to discuss the results and outlook [1]. Group 1: Financial Reporting - The financial results will be announced after market close on February 12, 2026 [1]. - A public conference call and live webcast will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results [1]. Group 2: Company Overview - 10x Genomics is a life science technology company focused on products that enhance the understanding of biology and improve human health [3]. - The company offers integrated research solutions, including instruments, consumables, and software for single cell and spatial biology, aiding researchers in comprehending complex biological systems [3]. - Its products contribute to advancements in various fields such as oncology, immunology, and neuroscience, leading to significant discoveries in health and disease [3].

Core Insights - 10x Genomics, Inc. will report its financial results for Q3 2025 on November 6, 2025, after market close [1] - A public conference call and live webcast will be held to discuss the results, business developments, and outlook [1] - The webcast will be available for replay for at least 45 days after the event [2] Company Overview - 10x Genomics is a life science technology company focused on products that enhance the understanding of biology and improve human health [3] - The company offers integrated research solutions, including instruments, consumables, and software for single cell and spatial biology [3] - Its products contribute to advancements in various fields such as oncology, immunology, and neuroscience, facilitating significant discoveries in health and disease [3]